Episode 78: Regulatory and Commercial Considerations for Hemp-Derived CBD

How do cannabis chemotypes shape market access? What’s the FDA’s position on CBD as a consumer product ingredient? Listen in as Dr. Duffy MacKay shares what he’s learned as the senior vice president of scientific and regulatory affairs at CV Sciences, a CBD company available in more than 7,300 retail locations. This business-focused discussion is adapted from a session at the Emerge Virtual Cannabis Conference. Are you still reading? Start listening and join the conversation around hemp-derived CBD. Cannabis Tech Talks are brought to you thanks to the support of Polyscience. Discover how Polyscience is changing the world of temperature control by visiting Polyscience.com.